BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 37.00
+1.00 (2.78%)
At close: Oct 29, 2026
BIONET Therapeutics Revenue
BIONET Therapeutics had revenue of 104.47M TWD in the half year ending June 30, 2026, with 175.20% growth. This brings the company's total for the last twelve months to 196.63M, up 86.07% year-over-year. In the year 2025, BIONET Therapeutics had annual revenue of 154.48M with 89.97% growth. That makes BIONET Therapeutics the 39,347th largest company in the world by revenue and 2,043rd in Taiwan.
Revenue (ttm)
196.63M
Revenue Growth
+86.07%
P/S Ratio
13.17
Revenue / Employee
n/a
Employees
105
Market Cap
2.59B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.48M | 73.16M | 89.97% |
| Dec 31, 2024 | 81.32M | 75.95M | 1,414.60% |
| Dec 31, 2023 | 5.37M | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.